T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Pentair
PNR
$10.7B
| $15.8M | ﹤0.01% |
217,339
+3,418
| +2% | +$221K |
|
1002
Fortune Brands Innovations
FBIN
$5.78B
| $15.8M | ﹤0.01% |
207,296
-156
| -0.1% | -$10.3K |
|
1003
UDR
UDR
$12.2B
| $15.7M | ﹤0.01% |
409,537
+10,253
| +3% | +$357K |
|
1004
First American
FAF
$7.56B
| $15.7M | ﹤0.01% |
243,000
-12,522
| -5% | -$714K |
|
1005
Doximity
DOCS
$4.74B
| $15.6M | ﹤0.01% |
557,636
-93,878
| -14% | -$2.22M |
|
1006
Silicon Laboratories
SLAB
$7.28B
| $15.5M | ﹤0.01% |
117,316
+68,285
| +139% | +$7.47M |
|
|
AMAM
1007
DELISTED
Ambrx Biopharma Inc
AMAM
| $15.4M | ﹤0.01% |
1,084,247
+262,683
| +32% | +$2.98M |
|
1008
Voya Financial
VOYA
$9.16B
| $15.4M | ﹤0.01% |
211,412
+41,439
| +24% | +$2.89M |
|
1009
Molson Coors Class B
TAP
$7.85B
| $15.4M | ﹤0.01% |
250,809
+5,389
| +2% | +$324K |
|
1010
iShares MSCI EAFE ETF
EFA
$80.3B
| $15.2M | ﹤0.01% |
201,924
+201,414
| +39,493% | +$14.2M |
|
1011
Brookfield Renewable
BEP
$10.6B
| $15.1M | ﹤0.01% |
576,113
-12,255
| -2% | -$290K |
|
1012
SLM Corp
SLM
$5.22B
| $15.1M | ﹤0.01% |
790,210
+316,730
| +67% | +$4.78M |
|
1013
Henry Schein
HSIC
$10B
| $15.1M | ﹤0.01% |
199,164
+362
| +0.2% | +$25.3K |
|
1014
Travel + Leisure Co
TNL
$4.58B
| $15M | ﹤0.01% |
384,907
-147,263
| -28% | -$5.34M |
|
1015
Zoom
ZM
$32.2B
| $15M | ﹤0.01% |
208,595
-1,098,253
| -84% | -$72.6M |
|
1016
Crown Holdings
CCK
$12.9B
| $14.9M | ﹤0.01% |
162,089
+8,948
| +6% | +$759K |
|
1017
iShares Core MSCI EAFE ETF
IEFA
$196B
| $14.9M | ﹤0.01% |
212,100
+34,552
| +19% | +$2.28M |
|
1018
Qorvo
QRVO
$8.68B
| $14.7M | ﹤0.01% |
130,762
+4,806
| +4% | +$464K |
|
1019
Tenaya Therapeutics
TNYA
$164M
| $14.7M | ﹤0.01% |
4,544,543
+69,377
| +2% | +$150K |
|
|
SKX
1020
DELISTED
Skechers
SKX
| $14.7M | ﹤0.01% |
235,741
+1,253
| +0.5% | +$67.5K |
|
1021
Sana Biotechnology
SANA
$1.1B
| $14.7M | ﹤0.01% |
3,594,025
-3,432,116
| -49% | -$12.6M |
|
1022
Riot Platforms
RIOT
$7.21B
| $14.5M | ﹤0.01% |
938,205
+845,204
| +909% | +$10.2M |
|
1023
Healthpeak Properties
DOC
$14.3B
| $14.5M | ﹤0.01% |
732,295
-5
| -0% | -$88 |
|
1024
Moog Inc Class A
MOG.A
$13.5B
| $14.5M | ﹤0.01% |
100,015
-28,085
| -22% | -$3.63M |
|
1025
C4 Therapeutics
CCCC
$502M
| $14.5M | ﹤0.01% |
2,558,480
+372,021
| +17% | +$848K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.